3T3-L1 obesity reactive oxygen species Rg1 zebrafish a b s t r a c t Background: Ginsenoside Rg1 is a class of steroid glycoside and triterpene saponin in Panax ginseng. Many studies suggest that Rg1 suppresses adipocyte differentiation in 3T3-L1. However, the detail molecular mechanism of Rg1 on adipogenesis in 3T3-L1 is still not fully understood. Methods: 3T3-L1 preadipocyte was used to evaluate the effect of Rg1 on adipocyte development in the differentiation in a stage-dependent manner in vitro. Oil Red O staining and Nile red staining were conducted to measure intracellular lipid accumulation and superoxide production, respectively. We analyzed the protein expression using Western blot in vitro. The zebrafish model was used to investigate whether Rg1 suppresses the early stage of fat accumulation in vivo. Results: Rg1 decreased lipid accumulation in early-stage differentiation of 3T3-L1 compared with intermediate and later stages of adipocyte differentiation. Rg1 dramatically increased CAAT/enhancer binding protein (C/EBP) homologous protein-10 (CHOP10) and subsequently reduced the C/EBPb transcriptional activity that prohibited the initiation of adipogenic marker expression as well as triglyceride synthase. Rg1 decreased the expression of extracellular signal-regulated kinase 1/2 and glycogen synthase kinase 3b, which are also essential for stimulating the expression of CEBPb. Rg1 also reduced reactive oxygen species production because of the downregulated protein level of nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) oxidase 4 (NOX4). While Rg1 increased the endogenous antioxidant enzymes, it also dramatically decreased the accumulation of lipid and triglyceride in high fat diet-induced obese zebrafish. Conclusion: We demonstrated that Rg1 suppresses early-stage differentiation via the activation of CHOP10 and attenuates fat accumulation in vivo. These results indicate that Rg1 might have the potential to reduce body fat accumulation in the early stage of obesity.
Introduction
High fat diet (HFD)-induced obesity is a serious public health problem worldwide, and is an underlying factor of metabolic syndrome as well as multiple postmodern noncommunicable diseases [1] . Body fat accumulation is caused by different of processes including hyperplasia and hypertrophic in obesity [2] . Hyperplasia and hypertrophic adipocyte are induced as a result of adipogenesis, which is the process of adipocyte differentiation for cell proliferation and lipid accumulation [3] . During the mitotic clonal expansion phase, which is the early stage of adipogenesis in adipocyte, CAAT/enhancer binding protein b (C/EBPb; which starts to coordinate the multiple transcriptional regulation by turning on major adipogenic factors), C/EBPa, and peroxisome proliferator-activated receptor g (PPARg) are expressed [4, 5] . Moreover, adipogenic factors markedly upregulates the adipocyte protein 2 (aP2) and triglyceride synthesis enzymes such as lysophosphatidic acid acyltransferase (LPAT), Lipin1, and diacylglycerolacyltransferase 1 (DGAT1) during the late stage of adipogenesis [6, 7] .
The development of adipocyte is also associated with an oxidative stress in obesity [8] . The abundance of reactive oxygen species (ROS), which is generated by nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) oxidase 4 (NOX4) during adipogenesis, leads to increased cellular damage and insulin resistance [9, 10] . By contrast, the endogenous antioxidant enzymes, such as the enzyme superoxide dismutase 1 (SOD1), SOD2, catalase (CAT) glutathione peroxidase (GPx), and glutathione reductase (GR), have been reported to lead to low levels of enzymes in obese mice [11] .
Recently, it has been reported that ROS is important in stimulating the mitotic clonal expansion (MCE) during adipogenesis by increasing the C/EBPb activity [12] . Moreover, C/EBP homologous protein-10 (CHOP10) functions as a negative regulator of C/EBPb in the early stage of adipogenesis [13] . Mitogen-activated protein kinases (MAPKs), which include three groupsdextracellular signalregulated kinases (ERK), c-Jun amino-terminal kinases (JNK), and p38 MAPK, are intracellular signaling pathways that play a pivotal role in many essential cellular processes such as proliferation and differentiation [14] . The phosphorylation of ERK regulates cell proliferation and is required to induce the expression of C/EBPb for initiating the differentiation process in the early stage of adipogenesis [15, 16] . Moreover, phosphorylation of C/EBPb at a consensus ERK/glycogen synthase kinase 3b (GSK3b) site is required for the activation of primary adipogenic factor expression including C/EBPa, PPARg, and aP2 [17] . Therefore, regulation of the early stage of marker C/EBPb is important to suppress the development of adipocyte in obese individuals.
The higher intake of fruits and herbs in comparison with HFD is correlated with a dramatically decreased risk of obesity and obesity-associated noncommunicable diseases [18] . These fruits and herbs contain numerous bioactive compounds that have the potential to be used as therapeutic agents for noncommunicable diseases including obesity [19, 20] .
Panax ginseng is a traditional herbal medicine used around the world. Ginsenoside is an active component of P. ginseng and has been elucidated to have anti-inflammatory, antioxidant, anticancer, and antidiabetes effects [21e23]. Rg1 is a triterpene saponin and one of the principal active compounds extracted from P. ginseng. Recently, we and other groups reported that Rg1 stimulates glucose uptake, mitigates oxidative stress in rat skeletal muscles and suppresses triglyceride accumulation in 3T3-L1 [24e26]. However, the underlying contribution of Rg1 to the early stage of adipogenesis and ROS promotion remains unclear.
Thus, we investigated how Rg1 regulates the aforementioned gene expression including adipocyte differentiation makers, antioxidant enzymes, CHOP10, and GSK3b in the development of 3T3-L1 in a stage-dependent manner. Moreover, we have evaluated the effect of Rg1 on lipid and triglyceride accumulation in the HFDinduced obese zebrafish model.
Materials and methods

Materials
Ginsenoside Rg1 (!95% purity) was purchased from ChengDu Biopurify Phytochemicals Ltd. (Biopurify, ChengDu, China). 3T3-L1 preadipocyte was purchased from the ATCC (CL-173; American Type Culture Collection, Manassas, VA, USA). Dulbecco's modified Eagle's medium (DMEM), bovine calf serum (BCS), fetal bovine serum (FBS), penicillinestreptomycin (P/S), phosphate-buffered saline (PBS), and trypsineEDTA were purchased from Gibco (Gaithersburg, MD, USA). Dexamethasone (DEX), 3-isobutyl-1-methylxanthine (IBMX), insulin, Oil Red O, nitroblue tetrazolium (NBT), and N-acetyl cysteine (NAC) were purchased from Sigma (St. Louis, MO, USA). Peroxide-sensitive fluorophore 2,7 0 -dichlorodihydrofluoresceindiacetate (DCF-DA) was purchased from Cell Biolabs (San Diego, CA, USA). 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carbox-anilide (XTT) reagent and N-methyl dibenzopyrazine methyl sulfate (PMS) were purchased from Welgene (Gyeongsan, South Korea). Unless noted otherwise, all chemicals were also purchased from Sigma Chemical Co.
Antibodies specific for aP2, JNK, p38MAPK, phospho-p38MAPK (Thr180/Tyr182), ERK1/2, and GPx were purchased from Cell Signaling Technology (Danvers, MA, USA). Antibodies against CHOP10, C/EBPb, C/EBPa, PPARg, LPAT, Lipin1, DGAT1, phospho-ERK1/2 (Thr202/Tyr204), phospho-JNK (Thr183/Tyr185), phospho-GSK3b, GSK3b, GR, SOD1, CAT, NOX4, and b-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Cell culture
3T3-L1 preadipocyte were cultured in DMEM medium containing 3.7 g/L sodium bicarbonate, 1% P/S, and 10% BCS at 37 C in 5% CO 2 . Two-day postconfluent cells were induced to differentiate via treatment with 10% FBS and MDI hormone cocktail (0.5mM IBMX, 1.0mM DEX, and 5 mg/mL insulin; Day 0). The medium was replaced with DMEM containing 5 mg/mL insulin and 10% FBS for a further 2 d (Day 2). This medium was then replaced with fresh DMEM containing 10% FBS every other day until the indicated time point (Days 6e8). Next, 25mM, 50 mM, and 100mM Rg1 and 5mM NAC were dissolved in DMSO. The final concentration of DMSO was 0.25% in all experiments.
Cell viability assay
3T3-L1 preadipocyte (1 Â 10 4 cells/well) in 96-well plates were treated with Rg1 (0mM, 25mM, 50mM, 100mM, and 200mM) and incubated for 24 h. XTT reagent and PMS were added to the culture and incubated for 2 h at 37 C. Soluble formazan salt in the medium was measured by enzyme-linked immunosorbent assay (ELISA) reader Wallac 140 victor (Perkin-Elmer, Boston, MA, USA) at 450 nm against 690 nm.
Oil Red O staining
Differentiated 3T3-L1 cells, which were washed with PBS, were fixed with 10% formaldehyde at 4 C for 1 h. After washing with PBS, the fixed cells were stained with 0.5% Oil Red O in 60:40 (v/v) Oil Red O/H 2 O for 2 h at room temperature, and then washed three times with water. Lipid accumulation was observed with an inverted light Olympus CKX41 microscope (Olympus, Tokyo, Japan). Then, 100% isopropanol was used to elute Oil Red O dye, and the absorbance at 490 nm was determined using ELISA reader Wallac 140 victor (Perkin-Elmer).
NBT assay
3T3-L1 preadipocytes were grown to confluence and induced to differentiate into adipocytes, as previously described. Production of ROS was detected via an NBT assay. Nitrobluetetrazolium is reduced by ROS to a dark blue, insoluble form of NBT called formazan [11] . On Day 8 after induction, the cells were incubated for 90 min in PBS containing 0.2% NBT. Formazan was dissolved in 100% acetic acid, and the absorbance was determined using the ELISA reader Wallac 140 victor (Perkin-Elmer) at 570 nm.
Measurement of intracellular ROS production
3T3-L1 preadipocyte (1 Â 10 4 cells/well) in 96-well plates were differentiated for 24 h. Differentiated cells were detected by 20mM DCF-DA. After incubation for 30 min in 5% CO 2 incubator at 37 C, 3T3-L1 cells were washed with PBS, and absorbance was determined by ELISA reader Wallac 140 victor (Perkin-Elmer) at 480 nm against 530 nm.
Western blotting
Cells were harvested by lysis buffer containing protease inhibitors and phosphatase inhibitor cocktail II, III. Protein extracts (25 mg) were separated via sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a polyvinyl difluoride (PVDF) membrane. The membranes were blocked with 5% nonfat dry milk and immunoblotted with primary antibodies specific for indicated proteins for overnight. Secondary antibodies conjugated with horseradish peroxidase (1:5,000) were applied for 4 h. The bands were visualized by enhanced chemiluminescence, and proteins were detected with LAS image software (Fuji, New York, NY, USA).
Animal husbandry
Wild-type adult zebrafish (Danio rerio) were initially obtained from Chungnam National University (Daejeon, South Korea). Embryos and larvae were obtained by natural mating and raised in embryo water containing Sea salts (Sigma) of 60 mg/mL until 5 d postfertilization (5 dpf). Then, larvae were maintained in 100-mm plate at a density of about 20 larvae per 100 mL, and fed hardboiled egg yolk as an HFD once a day in the presence or absence of indicated compounds for 12e15 d (17e20 dpf). Zebrafish larvae used for imaging analysis were starved for 24 h to empty the digestive tract prior to Nile red staining.
Nile red staining, fluorescence imaging
The stock solution (1.25 mg/mL) of Nile red (Invitrogen N-1142) was prepared in acetone and stored in the dark at À20 C. For staining of fish, stock solution was diluted to 50 ng/mL in egg water and incubated for 5e10 min at 28 C in the dark. Fishes were washed with distilled water three times and anesthetized with a few drops of tricaine stock solution (Sigma; 4 mg/mL, pH 7.0). Fishes were mounted in 3% methylcellulose, and Nile red staining was imaged under ECLIPSE E600 (Nikon, Tokyo, Japan) fluorescence microscope, which was used for green fluorescent imaging.
Quantification of triglycerides
Triglyceride was measured using a total triglyceride assay kit (Zen-Bio, Research Triangle Park, NC, USA). Cells and zebrafish were washed with phosphate-buffered saline to remove residual medium, and the cells were lysed with lysis buffer. Triglyceride was digested with Reagent B for 2 h to release hydrolyzed glycerols into the buffer. Diluted hydrolysates were incubated with Reagent A containing peroxidase to produce quinoneimine dye, which shows an absorbance maximum in spectrophotometric detection at 540 nm.
Statistical analysis
All values are expressed as mean standard deviation values. All data were obtained at least in triplicate or hexaplicate experiments. Differences among multiple groups were determined using oneway analysis of variance followed by Duncan's multiple range test using the SAS 9.0 software (SAS Institute, NC, USA). A p value < 0.05 was considered statistically significant.
Results
Rg1 attenuates lipid accumulation via regulation of C/EBPa, PPARg, and aP2 in 3T3-L1
Ginsenoside Rg1 is an active component of ginseng as triterpenoid saponins, as shown in Fig. 1A . We performed the XTT assay to analyze the viability of 3T3-L1 cells treated with Rg1 for 24 h. As shown in Fig. 1B , Rg1 at 200mM in 3T3-L1 was found to be toxic to cells. Therefore, the concentrations of 25mM, 50mM, and 100mM Rg1 were selected for further investigation. Moreover, we measured the cytotoxicity of NAC, which has been used as an inhibitor of adipocyte differentiation in 3T3-L1. The concentration of 5mM NAC was not found to be toxic to cells compared with control.
We investigated the effects of Rg1 on lipid accumulation in 3T3-L1 cells. Rg1 decreased lipid accumulation in a dose-dependent manner during differentiation, as shown in Fig. 2A . Notably, the concentration of 100mM Rg1 showed a great reduction effect on lipid accumulation (more than 70%) compared with control. NAC, used as a positive control, strongly decreases lipid accumulation. Consistently, Rg1 suppressed adipogenesis-related key factors including C/EBPa, PPARg, and aP2 in a dose-dependent manner, as shown in Fig. 2B and Figs. S1AeS1C.
Rg1 downregulates triglyceride synthesis enzymes during differentiation in 3T3-L1
Lipid droplet in adipose tissue is mainly composed of triglycerides and sterol esters. A lack of triglyceride synthesis is known to block adipocyte differentiation [27] . The key enzymes for lipogenesis including LPAT, Lipin1, and DGAT1 catalyze triglyceride synthesis in adipose tissue [28e30] .
To gain a better understanding of the molecular mechanism underlying the inhibition of triglyceride effect of Rg1, we used Western blotting to analyze the protein expression of LPAT, Lipin1, and DGAT1. Consistent with the increase in the adipogenic differentiation markers, the expression of key enzymes in triglyceride synthesis including LPAT, Lipin1, and DGAT increased substantially in control, as shown in Fig. 2C and Figs. S1DeS1F. By contrast, Rg1 dramatically derepressed the expression of LPAT, Lipin1, and DGAT1 in a dose-dependent manner compared to values in the cell without Rg1 treatment.
In particular, Lipin1 induces the expression of PPARg via direct physical interaction and leads to elevated aP2 expression in the late stage of adipocyte differentiation [7, 31] . These lines of evidence prompted us to hypothesize that Rg1 may be a powerful reducer of adipogenesis at the early stage of adipocyte differentiation. Moreover, the product of ROS is required to initiate preadipocyte differentiation into adipocyte [32] . Again, to determine whether Rg1 modulates early stage-specific adipocyte differentiation in 3T3-L1, the generation of intracellular ROS was measured using the NBT assay. Consistent with the decrease in intracellular lipid accumulation, Rg1 at 100mM significantly decreased ROS production in the early stage (Days 0e2) of adipocyte differentiation compared to cells treated with 100mM Rg1 in the intermediate stage (Days 2e4) and later stage (Days 4e6) of adipocyte differentiation, as shown in Fig. 3C .
To assess the changes in the activity of ROS-related antioxidant enzymes at an early stage of adipogenesis with MDI in the absence or presence of 25mM, 50mM, and 100mM Rg1, the expression of GPx, GR, SOD1, CAT, and NOX4 was determined as an indicator of ROS by Western blotting. As shown in Fig. 4B and Figs. S2AeS2E, Rg1 was associated with a significant enhancer of the activities of the protective endogenous enzymes GPx, GR, and SOD1 at an early stage of adipogenesis, even at the lowest dose. The measured protein expression in the cells with the presence of 25mM, 50mM, and 100 mM Rg1 significantly increased by 37.2%, 42.9%, and 72.3% for GPx, and 62.9%, 73.1%, and 99.3% for GR, and 35.9%, 53.2%, and 75.6% for SOD1, respectively. Notably, CAT activity was increased in a dosedependent manner. Loss of NOX4 suppresses ROS generation and insulin-induced terminal differentiation to adipocytes [33, 34] . Furthermore, we observed that Rg1 consistently decreased the significant expression of NOX4 protein compared with control.
These results indicate that Rg1 preferentially repressed the initiation of adipocyte differentiation via upregulation of endogenous antioxidant enzyme and downregulation of ROS-generating enzyme NOX4 during the early stage of adipogenesis.
Effects of Rg1 on early adipogenic factor by regulating antioxidant enzymes during early adipogenesis in 3T3-L1 cells
To gain a better understanding of the molecular mechanism uderlying the Rg1 effect at an early stage of adipocyte differentiation, we performed Western blotting to analyze the protein expression of C/EPBb and CHOP10 in the early stage of adipogenesis (Day 2). As shown in Fig. 5A and Figs. S3A, S3B, the expression of C/ EPBb at an early stage of adipocyte differentiation with the absence of Rg1 was increased compared to that of the undifferentiated cells. By contrast, the cells treated with Rg1 showed a significant decrease in protein levels of C/EPBb at an early stage of adipocyte adipogenesis in a dose-dependent manner. CHOP10 binds to C/ EPBb, preventing it from DNA regulatory sequence to regulate transcription. The expression of CHOP10 was downregulated in the early stage of adipocyte differentiation. Meanwhile, cells treated with Rg1 in the early stage of adipocyte differentiation dramatically attenuated the expression of CHOP10 protein in a dose-dependent manner.
Furthermore, C/EPBb is activated by phosphorylation of MAPK and GSK3b at the beginning of the S phase concurrent with the translocation of GSK3b from cytosol into the nucleus in the later stage of adipocyte differentiation [35] . To further elucidate the molecular mechanism of the inhibitory effect of Rg1 at the early stage of adipogenesis, we investigated the possibility of Rg1 acting as a MAPK and GSK3b suppressor. We observed that Rg1 derepressed phosphorylation of ERK1/2 and GSK3b compared with control in a dose-dependent manner, but not JNK1/2 and p38 MAPK repression by Rg1 in the early stage of adipocyte differentiation as shown in Fig. 5B and Figs. S3CeS3E.
These analysis data clearly indicated that Rg1 suppresses the early stage of gene expression cascade including CHOP10, ERK1/2, and GSK3b, and sequentially impaired adipocyte differentiation.
Rg1 supplement impair lipid accumulation in HFD-induced obese zebrafish
The afore-mentioned findings suggested that Rg1 disturbed the lipid accumulation via regulation of the early stage of adipocyte differentiation suppressor CHOP10 and adipogenesis cues in 3T3-L1. To finalize the analysis of the effect of Rg1 on lipid accumulation in vivo, we used HFD-induced obese zebrafish that possess structural and functional similarities with obese humans. As shown in Fig. 6AeC , significant increases in the fat mass and the content of triglyceride, which was quantified by driving the fluorescent intensity of Nile red staining or triglyceride measurement assay, were evident in the diet-induced obesity (DIO) zebrafish group compared with those in the nonfat diet control (NFD) group. By contrast, DIO zebrafish treated with Rg1 showed suppressed body fat accumulation in a dose-dependent manner. Consistent with this, the level of triglycerides was also inhibited when the DIO group was treated with Rg1. Hence, these results indicate that dietary Rg1 is beneficial for suppression of fat accumulation in the HFD-induced obese zebrafish model.
Discussion
In this study, we conducted two independent experiments to determine whether Rg1 suppresses adipocyte differentiation in the development of 3T3-L1 in a stage-dependent manner and fat accumulation in HFD-induced obese zebrafish.
C/EPBb, a transcriptional factor of the C/EBPa, is expressed at the early stage of adipocyte differentiation [36] and is released by CHOP10 as it undergoes downregulation in the early stage of adipocyte differentiation [37] . We observed that the presence of Rg1 attenuates early-stage-specific adipocyte differentiation via the activation of CHOP10, which systemically suppresses adipogenesis cues such as C/EBPa and PPARg and stimulates the expression of fatty acid synthase, which is essential for generating triglyceride droplets [38, 39] . We noted that fatty acid synthesis enzymes including LPAT, Lipin1, and DGAT1 were decreased in early-stage differentiation of 3T3-L1 treated with Rg1 compared with control. Attenuation of both adipogenic markers and fatty acid synthase can result in the suppression of lipid accumulation and ROS production, which were determined using Oil Red O staining and the NBT assay, during the early stage of differentiation of 3T3-L1 with the presence of Rg1 compared to the intermediate and later stages of differentiation of 3T3-L1 with the presence of Rg1. The DCF-DA assay has also revealed that Rg1 inhibited the accumulation of intracellular ROS production in a dose-dependent manner during the early stage of differentiation of 3T3-L1 preadipocytes.
ROS-associated endogenous antioxidant enzymes such as SODs, SOD1, and CAT convert O 2 e into H 2 O 2 to prevent cytotoxicity by ROS production. In particular, their primary mechanism to eliminate H 2 O 2 and lipid peroxides in the cytosol and mitochondria is catalyzed by GPx, which uses glutathione to reduce H 2 O 2 and hydroperoxides into water and alcohols, respectively [40, 41] . We observed that GPx, GR, SOD1, and CAT were consistently increased in a dose-dependent manner during the early stage of differentiation of 3T3-L1 preadipocytes with the presence of Rg1. The production of ROS is released via the balance of antioxidant and pro-oxidant enzymes. NOX4 acts as a pro-oxidant enzyme that produces ROS levels and plays a crucial role of the electron donor for NADPH [42] . We observed that the presence of Rg1 significantly decreased the gene expression of endogenous pro-oxidant enzyme NOX4 during early-stage differentiation of 3T3-L1 preadipocytes.
The MAPK signaling pathway is ubiquitously expressed, highly conserved GSK3b, and involved in adipocyte differentiation [43] . ERK is one of the MAPKs that have been suggested to play a role in the development of insulin resistance and obesity [44] . We observed that Rg1 inhibited the phosphorylation of GSK3b and ERK stimulated during early-stage differentiation of 3T3-L1 preadipocytes in a dose-dependent manner compared to control, but not the phosphorylation of p38 MAPK.
The aforementioned evidence suggested that Rg1 attenuated lipid accumulation via regulation of early-stage adipogenic markers and its downstream target molecules. These results indicate that Rg1 can repress fat accumulation in vivo. To examine whether Rg1 attenuates body fat accumulation, we used the HFD-induced zebrafish model. We observed that in HFD-induced obese zebrafish, levels of fluorescence intensity were increased, whereas the HFD-fed and Rg1-treated group showed significant levels of decrease in fluorescence intensity in a dose-dependent manner.
Moreover, the HFD-fed and Rg1-treated group showed reduced triglyceride content by approximately 60% compared with control to HFD without Rg1 treatment group. These results indicate that Rg1 decreased the accumulation of lipids and triglycerides in HFDinduced obese zebrafish.
In conclusion, the current data demonstrate that Rg1 increases CHOP10 during the early stage of differentiation of 3T3-L1 preadipocytes, which might disrupt the multiple downstream of adipogenic cascades and subsequently attenuate lipid accumulation in vitro and in vivo. Hence, we suggest that Rg1 might have the potential to beneficially suppress body fat accumulation in the early stage obesity.
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